Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOlivier F. Bertrand
About this trial
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults (>=18 years of age)
Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
Identified in the institutional procedure database
Disqualifiers
Incomplete or non-available data on the post-procedural clinical follow-up
Procedures where other devices were used in combination with drug-eluting balloons.
Trial population
Consecutive adult patients registered in the institutional procedural database who underwent a coronary angioplasty with drug-eluting balloons exclusively between January 2010 and December 2025.
Trial design
Design model
Case-only
Time perspective
Other
Treatments tested in this trial
DEB
DeviceUse of DEB to treat coronary lesions
Treatment groups
1,500 Participants
are divided into 1 treatment groupGroup A: DEB1 intervention
Trial outcomes
Primary outcomes
1
Major Adverse Cardiovascular Events
defined as: * Cardiovascular death * Myocardial infarction * Target vessel revascularization * Cerebrovascular event * Hospitalization due to heart failure
Time frame
within 10 years of inclusionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Olivier F. Bertrand
Lead sponsor
Laval University
Sponsor institution
Source ClinicalTrials.gov